These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31016669)

  • 1. In Silico Approaches to Predict Drug-Transporter Interaction Profiles: Data Mining, Model Generation, and Link to Cholestasis.
    Jain S; Ecker GF
    Methods Mol Biol; 2019; 1981():383-396. PubMed ID: 31016669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of Drug-Induced Cholestasis Potential in Sandwich-Cultured Human Hepatocytes.
    Deferm N; Richert L; Van Brantegem P; De Vocht T; Qi B; de Witte P; Bouillon T; Annaert P
    Methods Mol Biol; 2019; 1981():335-350. PubMed ID: 31016665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting Drug-Induced Cholestasis with the Help of Hepatic Transporters-An in Silico Modeling Approach.
    Kotsampasakou E; Ecker GF
    J Chem Inf Model; 2017 Mar; 57(3):608-615. PubMed ID: 28166633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a mechanistic biokinetic model for hepatic bile acid handling to predict possible cholestatic effects of drugs.
    Notenboom S; Weigand KM; Proost JH; van Lipzig MMH; van de Steeg E; van den Broek PHH; Greupink R; Russel FGM; Groothuis GMM
    Eur J Pharm Sci; 2018 Mar; 115():175-184. PubMed ID: 29309877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ex Vivo Model in Cholestasis Research.
    Karsten REH; Oosterhuis D; van Wijk LA; Olinga P
    Methods Mol Biol; 2019; 1981():351-362. PubMed ID: 31016666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Change in Bile Flow: Looking Beyond Transporter Inhibition in the Development of Drug-induced Cholestasis.
    Garzel B; Zhang L; Huang SM; Wang H
    Curr Drug Metab; 2019; 20(8):621-632. PubMed ID: 31288715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Model Systems for Studying the Role of Canalicular Efflux Transporters in Drug-Induced Cholestatic Liver Disease.
    Stieger B; Mahdi ZM
    J Pharm Sci; 2017 Sep; 106(9):2295-2301. PubMed ID: 28385542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting drug-induced liver injury: The importance of data curation.
    Kotsampasakou E; Montanari F; Ecker GF
    Toxicology; 2017 Aug; 389():139-145. PubMed ID: 28652195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organotypic 3D HepaRG Liver Model for Assessment of Drug-Induced Cholestasis.
    Ramaiahgari SC; Ferguson SS
    Methods Mol Biol; 2019; 1981():313-323. PubMed ID: 31016663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Machine Learning Models to Predict Inhibition of the Bile Salt Export Pump.
    McLoughlin KS; Jeong CG; Sweitzer TD; Minnich AJ; Tse MJ; Bennion BJ; Allen JE; Calad-Thomson S; Rush TS; Brase JM
    J Chem Inf Model; 2021 Feb; 61(2):587-602. PubMed ID: 33502191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organic solute transporter OSTα/β is overexpressed in nonalcoholic steatohepatitis and modulated by drugs associated with liver injury.
    Malinen MM; Ali I; Bezençon J; Beaudoin JJ; Brouwer KLR
    Am J Physiol Gastrointest Liver Physiol; 2018 May; 314(5):G597-G609. PubMed ID: 29420067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for development of cholestatic drug-induced liver injury: inhibition of hepatic basolateral bile acid transporters multidrug resistance-associated proteins 3 and 4.
    Köck K; Ferslew BC; Netterberg I; Yang K; Urban TJ; Swaan PW; Stewart PW; Brouwer KL
    Drug Metab Dispos; 2014 Apr; 42(4):665-74. PubMed ID: 24154606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatobiliary transporters in drug-induced cholestasis: a perspective on the current identifying tools.
    de Lima Toccafondo Vieira M; Tagliati CA
    Expert Opin Drug Metab Toxicol; 2014 Apr; 10(4):581-97. PubMed ID: 24588537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and analysis of a human hepatotoxicity database suitable for QSAR modeling using post-market safety data.
    Zhu X; Kruhlak NL
    Toxicology; 2014 Jul; 321():62-72. PubMed ID: 24721472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-silico approach for drug induced liver injury prediction: Recent advances.
    Saini N; Bakshi S; Sharma S
    Toxicol Lett; 2018 Oct; 295():288-295. PubMed ID: 29981923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yangonin protects against cholestasis and hepatotoxity via activation of farnesoid X receptor in vivo and in vitro.
    Gao X; Fu T; Wang C; Ning C; Liu K; Liu Z; Sun H; Ma X; Huo X; Yang X; Zou M; Meng Q
    Toxicol Appl Pharmacol; 2018 Jun; 348():105-116. PubMed ID: 29660435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimeric TK-NOG mice: a predictive model for cholestatic human liver toxicity.
    Xu D; Wu M; Nishimura S; Nishimura T; Michie SA; Zheng M; Yang Z; Yates AJ; Day JS; Hillgren KM; Takeda ST; Guan Y; Guo Y; Peltz G
    J Pharmacol Exp Ther; 2015 Feb; 352(2):274-80. PubMed ID: 25424997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UPLC-MS-based metabonomic analysis of intervention effects of Da-Huang-Xiao-Shi decoction on ANIT-induced cholestasis.
    Zhu G; Feng F
    J Ethnopharmacol; 2019 Jun; 238():111860. PubMed ID: 30965080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lignans from Schisandra sphenanthera protect against lithocholic acid-induced cholestasis by pregnane X receptor activation in mice.
    Fan S; Liu C; Jiang Y; Gao Y; Chen Y; Fu K; Yao X; Huang M; Bi H
    J Ethnopharmacol; 2019 Dec; 245():112103. PubMed ID: 31336134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-induced cholestasis.
    Bhamidimarri KR; Schiff E
    Clin Liver Dis; 2013 Nov; 17(4):519-31, vii. PubMed ID: 24099015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.